bell
The current prices are delayed by 15 mins, login to check live prices.
Dishman Carbogen Amcis Ltd share price logo

Dishman Carbogen Amcis Ltd

(DCAL)

₹212.5318.8%

as on 04:01PM, 14 Nov 2024

Overview
News
Financials
Q2 2024 Results
Technicals

Dishman Carbogen Amcis Ltd Share analysis

Excluding Excise Duty and Other Income, represents Net Revenue

Dishman Carbogen Amcis Ltd revenue growth forecast

Expected growth rate Q1, FY2023:-0.60%

Forecast

Actual

Source: S&P Global Market Intelligence

Dishman Carbogen Amcis Ltd Performance

  • Day's Low

    Day's High

    ₹197.7
    ₹214.66
  • 52 Week's Low

    52 Week's High

    ₹133
    ₹283
1 Month Return+ 13.15 %
3 Month Return+ 21.41 %
1 Year Return+ 28.34 %
Previous Close₹178.89
Open₹201.00
Volume91.12L
Upper Circuit-
Lower Circuit-
Market Cap₹3,332.11Cr

Dishman Carbogen Amcis Ltd Key Statistics

P/E Ratio-19.15
PEG Ratio2.38
Market Cap₹3,332.11 Cr
P/B Ratio0.91
EPS-9.79
Dividend Yield0
SectorPharmaceuticals
ROE0

Dishman Carbogen Amcis Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹3,332.11 Cr15.06%0.58-₹154 Cr₹2,615 Cr
NA₹4,808.85 Cr36.95%0.52-₹30 Cr₹1,369 Cr
NA₹7.91 Cr29.88%0.90NANA
NA₹4,498.32 Cr355.76%0.50₹33 Cr₹204 Cr
NA₹0.00 Cr-12.22%0.77NANA

About Dishman Carbogen Amcis Ltd

Dishman Carbogen Amcis Ltd is a Gujarat, India based pharmaceutical manufacturing firm, listed on National Stock Exchange and Bombay Stock Exchange. It is the leading supplier of active pharmaceutical ingredients (API) for pharmaceutical and biotechnology companies, and a contract manufacturer for generic APIs, complex intermediates and custom synthesis products. The company is committed to deliver high quality and reliable products, as well as integrated services, including advanced process technology, cGMP manufacturing practices and project management. Dishman Carbogen Amcis has strong research and development capabilities with an in-depth knowledge of chemistry, established IP and access to world class facilities that enables faster delivery of cost effective products to global customers.

Share Price: ₹212.53 per share as on 14 Nov, 2024 04:01 PM
Market Capitalisation: ₹3,332.11Cr as of today
Revenue: ₹789.04Cr as on September 2024 (Q3 24)
Net Profit: ₹33.09Cr as on September 2024 (Q3 24)
Listing date: 21 Sep, 2017
Chairperson Name: Janmejay R Vyas
OrganisationDishman Carbogen Amcis Ltd
HeadquartersGujarat
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Dishman Carbogen Amcis Ltd

  • Dishman Carbogen Amcis Reports Q2 Earnings - 14 Nov, 2024

    Dishman Carbogen Amcis Limited reported strong Q2 results with sales of INR 7,890.4 million and a net income of INR 330.9 million, reversing last year's loss. However, the six-month results showed a net loss of INR 444.8 million, indicating challenges ahead.

Insights on Dishman Carbogen Amcis Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 8.04% to 8.17% in Sep 2024 quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 31.16% to 31.28% in Sep 2024 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 525.21 Cr → 795.69 Cr (in ₹), with an average increase of 34.0% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, DCAL stock has moved up by 14.4%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -77.57 Cr → 33.09 Cr (in ₹), with an average increase of 334.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 62.1% return, outperforming this stock by 33.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 122.5% return, outperforming this stock by 128.1%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 59.32% of holdings in Sep 2024 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 1.28% to 1.03% in Sep 2024 quarter

Dishman Carbogen Amcis Ltd Financials

Value in ₹ crore
DetailsQ'3 23Q'4 23Q'1 24Q'2 24Q'3 24
Revenue₹586.59Cr (-)₹651.09Cr (↑11.00%)₹654.71Cr (↑0.56%)₹523.78Cr (↓20.00%)₹789.04Cr (↑50.64%)
Net Income-₹40.90Cr (-)-₹59.63Cr (↑45.79%)-₹69.92Cr (↑17.26%)-₹77.57Cr (↑10.94%)₹33.09Cr (↓142.66%)
Net Profit Margin-6.97% (-)-9.16% (↑31.42%)-10.68% (↑16.59%)-14.81% (↑38.67%)4.19% (↓128.29%)
Value in ₹ crore
Details2021202220232024
Total Assets₹5,744.81Cr (-)₹5,214.31Cr (↓9.23%)₹5,360.22Cr (↑2.80%)₹5,286.01Cr (↓1.38%)
Total Liabilities₹1,070.19Cr (-)₹982.53Cr (↓8.19%)₹1,245.91Cr (↑26.81%)₹1,233.43Cr (↓1.00%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹196.70Cr (-)-₹1.51Cr (↓100.77%)₹227.35Cr (↓15,156.29%)-₹52.90Cr (↓123.27%)₹24.17Cr (↓145.69%)

Index Inclusions

BSE Healthcare

₹42,509.23

0.17 (73.94%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

BSE Small-Cap

₹52,381.98

0.83 (429.19%)

Dishman Carbogen Amcis Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
59.32%
0.00
Foreign Institutions
8.17%
1.61
Mutual Funds
1.03%
-19.26
Retail Investors
31.28%
0.37
Others
0.2%
0.00

Dishman Carbogen Amcis Ltd Key Indicators

Details2020
Return On Equity %0.88
Details20202021202220232024
Return On Assets %2.67-2.870.35-0.56-2.9
Details20202021202220232024
Book Value Per Share (₹)364.25363.45353.89370.51358.9
Details20202021202220232024
Earning Per Share (₹)10.1-10.531.15-1.9-9.79

Dishman Carbogen Amcis Ltd Valuation

Dishman Carbogen Amcis Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-599.35x)

March 22, 2023

Today (-19.15x)

November 14, 2024

Industry (54.87x)

November 14, 2024

Highest (338.29x)

July 25, 2022

LowHigh

Dishman Carbogen Amcis Ltd Earnings and Dividends

  • Dishman Carbogen Amcis Ltd Earnings Results

    Dishman Carbogen Amcis Ltd’s net profit jumped 180.9% since last year same period to ₹33.09Cr in the Q2 2024-2025. On a quarterly growth basis, Dishman Carbogen Amcis Ltd has generated 142.66% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Dishman Carbogen Amcis Ltd Dividends May,2019

    In the quarter ending March 2019, Dishman Carbogen Amcis Ltd has declared dividend of ₹0.20 - translating a dividend yield of 0.09%.

    Read More about Dividends

Dishman Carbogen Amcis Ltd Technicals Summary

Bearish

Neutral

Bullish

Bullish

Dishman Carbogen Amcis Ltd is currently in a Bullish trading position according to technical analysis indicators.

FAQs on Dishman Carbogen Amcis Ltd

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Dishman Carbogen Amcis Ltd shares.

Dishman Carbogen Amcis Ltd (DCAL) share price today is ₹212.53

Dishman Carbogen Amcis Ltd is listed on NSE

Dishman Carbogen Amcis Ltd is listed on BSE

  • Today’s highest price of Dishman Carbogen Amcis Ltd is ₹214.66.
  • Today’s lowest price of Dishman Carbogen Amcis Ltd is ₹197.7.

PE Ratio of Dishman Carbogen Amcis Ltd is -19.15

PE ratio = Dishman Carbogen Amcis Ltd Market price per share / Dishman Carbogen Amcis Ltd Earnings per share

Today’s traded volume of Dishman Carbogen Amcis Ltd(DCAL) is 91.12L.

Today’s market capitalisation of Dishman Carbogen Amcis Ltd(DCAL) is ₹3332.11Cr.

Dishman Carbogen Amcis Ltd(DCALPrice
52 Week High
₹283
52 Week Low
₹133

Dishman Carbogen Amcis Ltd(DCAL) share price is ₹212.53. It is down -24.90% from its 52 Week High price of ₹283

Dishman Carbogen Amcis Ltd(DCAL) share price is ₹212.53. It is up 59.80% from its 52 Week Low price of ₹133

Dishman Carbogen Amcis Ltd(DCALReturns
1 Day Returns
33.64%
1 Month Returns
13.15%
3 Month Returns
21.41%
1 Year Returns
28.34%